Skip to page content

October M&A roundup: Motion control, consumer trends and gene editing


Walmart
Walmart announced plans to acquire Andover-based Alert Innovation.
Walmart

Check out the nine mergers and acquisitions of tech and life sciences companies we reported on in October.

  • Altra Industrial Motion Corp., a Braintree manufacturer and supplier of motion control, power transmission and automation products, will be acquired by Regal Rexnord Corp. for approximately $5 billion on an enterprise value basis. 
  • Bedford’s Aspen Technology Inc. acquired the German software company Inmation Software GmbH. Terms were not disclosed. 
  • Risk Strategies, an insurance brokerage and risk management firm, acquired Aquarius Capital Solutions Group, an actuarial firm with expertise in health care benefits, employee and retirement benefits. The deal’s terms were not made public. 
  • Stagwell, a New York marketing company, has acquired Epicenter Experience. The Quincy company built a platform which uses mobile location data and user surveys to analyze consumer trends. Stagwell said Epicenter would continue to be led by its current leadership team including co-founders CEO Paul Krasinski and CFO Lynne Lipinsky.
  • Eli Lilly & Co. is scooping up a local gene-editing startup at a 121% premium. The pharma giant will acquire Boston-based Akouos Inc. for $487 million up-front plus one non-tradeable contingent value right per share, which would put the value of the transaction at $610 million. 
  • The Korean pharma firm LG Chem is set to buy Aveo Oncology for $15 a share, a 40% premium, valuing the company at $566 million. 
  • Boston-based Imara Inc. will merge with Colorado-based Enliven Therapeutics Inc. The new company will focus on Enliven’s pipeline of oncology product candidates.
  • Andover-based Alert Innovation, a robotic e-grocery fulfillment company, will be acquired by Walmart. The startup said it began piloting its technology in Walmart’s first market fulfillment center in 2019. 
  • Alexion announced it has agreed to acquire Lexington-based LogicBio Therapeutics Inc. Alexion said it will acquire all outstanding shares of LogicBio for $2.07 per share through a subsidiary.

Sign up for The Beat, BostInno’s free daily innovation newsletter. See past examples here.


Keep Digging

News
Awards
News
News
News


SpotlightMore

See More
See More
See More
See More

Upcoming Events More

Nov
28
TBJ
Oct
10
TBJ
Oct
29
TBJ

Want to stay ahead of who & what is next? Sent daily, the Beat is your definitive look at Boston’s innovation economy, offering news, analysis & more on the people, companies & ideas driving your city forward. Follow the Beat.

Sign Up